Back to search

Article

Mismatch between clinical need and uptake: distributional health gains and health inequalities from SGLT2 inhibitors in type 2 diabetes in England

2026-08-10

Abstract excerpt

<title>Abstract</title> <p>Background Health inequalities remain a major public health challenge in England, with people living in more deprived areas experiencing poorer outcomes. Although SGLT2 inhibitors (SGLT2i) are clinically and cost-effective for type 2 diabetes mellitus (T2DM) and related cardiovascular and renal conditions, little is known about how their health benefits are distributed across deprivatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb07c013-b3ab-5df4-980d-3778d410c29b
DOI
10.21203/rs.3.rs-10371282/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mismatch between clinical need and uptake: distributional health gains and health inequalities from SGLT2 inhibitors in type 2 diabetes in EnglandDOI 10.21203/rs.3.rs-10371282/v1
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary careSemantic proximity
The Economic Impact of National Essential Public Health Service Package for Hypertension and Type-2 Diabetes: A Retrospective Province-wide Study in ChinaSemantic proximity
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity
Safety and effectiveness of SGLT2-inhibitors in people with type 2 diabetes over 70: UK population-based study using an Instrumental Variable approachSemantic proximity
Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary careSemantic proximity
Socioeconomic Factors and Out-of-Pocket Healthcare Spending Among Adults with Hypertension and Type 2 Diabetes: National Cohort InsightsSemantic proximity
Tackling the Inverse Care Law with pharmacist-led cardio-renal-metabolic service in a socioeconomically deprived population: A prospective scoping intervention studySemantic proximity
Geographical variation in the use of glucose-lowering drugs in type-2 diabetes in Denmark: A nationwide drug utilization studySemantic proximity
Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical dataSemantic proximity
Benefit take-up in the last year of life: a population-based study using linked data for England and WalesSemantic proximity
Estimating incremental healthcare costs of coexisting type 2 Diabetes among patients with coronary heart disease in Australia: a linked data analysisSemantic proximity
Exploring evidence of SGLT2 inhibitors use in Southeast Asia: a systematic reviewSemantic proximity
Select a neighboring publication to make it the new centre.